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ABSTRACT 
 
Doctor's perception of oral contraceptive products is very important for social 
marketing.  Though the obvious and important use of oral contraceptives is to prevent 
unwanted pregnancy, it is also found that awareness regarding non-contraceptive health 
benefit use of oral contraceptives is increasing.  As oral contraceptives have a lot of side 
effects, normally doctors go for low dose pills to avoid inconvenience and risk when 
prescribing a patient. In many cases, doctors give their own judgment on the basis of a 
number of factors in defining low dose pills.  It is evident that Nordette 28 and Marvelon 
are considered to be almost near considering the attributes – less side effect, low dose, 
reasonable price and patient's preference.  Femicon is separated from the rest of the 
group due to its low price and is perceived by the doctors as the least quality oral 
contraceptive. Doctors usually like to prescribe Ovostat and Marvelon to those patients 
who have more purchasing ability and considers price as a quality factor.  
 
 
INTRODUCTION 
 
Bangladesh, a least developed country, is burdened with its huge population (130 
million with a population density of 850 per square kilometer) and its growth. 
This is resulting into poor quality of life of the citizens – in general, and women 
members – in specific. The government, non-government and international 
organizations are well aware of this population boom problem.  At present a good 
number of social welfare organizations in cooperation with the government, non-
governmental organizations and international agencies are involved in the family 
planning, reproductive and nutritional programs of the country.  The purpose of 
these institutions is to use social marketing and supportive information, education 
and motivation programs to enhance the quality of life of Bangladeshi people 
living in rural and urban areas.  They also focus on producing and marketing 
products and services that offer improved health and welfare benefits to the 
members of society.  
 
Among such products and services, a variety of high quality non-clinical 
contraceptives, condoms, oral contraceptive pills, and packaged oral re-hydration 
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salt are available in the market.  In an effort to make the price itself a 
motivational factor, these products are made available at highly affordable, 
subsidized and competitive prices.  The aim is to help develop habit among low 
income people the use of contraceptives to lead a better quality life.  In this 
process, both the doctors and social marketing companies understanding is 
important.  In this respect if the companies can understand doctors perception and 
prescription pattern regarding the products and services they are marketing will 
help them in order, supply and distribution of such products.  In this paper, the 
focus is to find out the considerations of the doctors in prescribing the different 
brands of oral contraceptives available in the market for social marketing of oral 
contraceptives in Bangladesh.  
 
Even in oral contraceptive supply and distribution, customer segmentation is very 
much important. It is observed that doctors – the prescribers themselves – 
segregate the brands of oral contraceptives in different groups according to their 
ability to satisfy different customer needs.  Therefore, if the marketers place and 
promote these brands in line with the thoughts of the physicians, it would bring 
them more benefits both in terms of social responsibility and financial 
sustainability.  The study will help the social marketers to have a clear idea about 
the doctor's perspectives on oral contraceptives, which in turn will facilitate them 
to update and standardize their product line for a better achievement and response 
from the community market.  
 
 
RESEARCH OBJECTIVES 
 
Keeping the above context in mind the main objective of the study is set to find 
out doctors' perception towards different aspects related to the use of oral 
contraceptives. Specifically this study will look into (a) reasons for 
recommendations of oral contraceptives by the doctors, (b) doctors' quality 
perception about different brands of oral contraceptives, and (c) factors 
influencing doctors' advising a particular brand.  
 
 
METHODOLOGY 
 
The research is mainly exploratory in nature. Information was collected through a 
pre-designed questionnaire.  As a convenience sampling a total of one hundred 
(100) doctors were interviewed in four major cities of Bangladesh: 50 from 
Dhaka City, 30 from Chittagong and 10 each from Khulna and Rajshahi 
metropolitan cities. The respondents were selected purposively. The main 
selection criteria of these doctors were: (a) at least an MBBS degree or its 
equivalent approved by Bangladesh Medical and Dental Council, (b) being 
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engaged in practicing medicine, and (c) advising and/or prescribing oral 
contraceptives at the time of conducting the study.  
 
The study made use of sophisticated statistical tools to strengthen its findings. 
Other than simple frequency distribution and bi-variate contingency table, the 
study made use of 5-point Likert scale to determine quality perception of the 
brands.  To further analyze the findings of mean preference score for different 
quality dimensions (i.e., less side effect and acceptability of the brands to the 
patients), statistical measures like analysis of variance (ANOVA) and Tukey's 
critical value were used.  Finally a correspondence analysis tool is used to 
measure the relationship between the factors that influence the doctors to 
prescribe a certain brand of oral contraceptive.  
 
 
DOCTOR'S PERCEPTION OF ORAL CONTRACEPTIVES 
 
Reasons for Recommendations of Oral Contraceptives 
 
There are a number of reasons noted to recommend oral contraceptives by the 
physicians. The seven major reasons identified for which doctors usually 
recommend oral contraceptives is shown in Table 1. 
 
TABLE 1 
REASONS OF ORAL CONTRACEPTIVE RECOMMENDATION 
 
Reasons Response (%) 
1.  Birth control 33 
2.  Dysmenorrhea (difficulty in menstruation) 28 
3.  Irregular menstruation 14 
4.  Anemia due to blood loss 10 
5.  For abnormal menstrual bleeding 6 
6.  For excessive menstrual bleeding 5 
7.  Salpingitis (infection of fallopian tubes) 4 
Total 100 
 
The study noted that in only 33% cases doctors advise oral contraceptives for 
birth control purposes, but the rest 67% of the cases the doctors recommend to 
use oral contraceptive are other non contraceptive health benefits.  The main 
other use of pills are for treatment of dysmenorrhea (28%).  The doctors are also 
found to prescribe oral contraceptive to cure or allay menstrual infirmities of 
their patients, e.g., to regularize menstruation (14%), cure anemia (10%), reduce 
the abnormal menstrual blood (6%), and help excessive loss of menstrual blood 
(5%).  Only 4% doctors administered oral contraceptives for salpingitis to cure 
infection of fallopian tubes. 
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Though the obvious and important use of oral contraceptives is to prevent 
unwanted pregnancy, but these have also some additional health benefits.  It is 
found that awareness about non-contraceptive health benefit use of oral 
contraceptives are also increasing. It can be mentioned here that the contraceptive 
pills' packets contain a number of vitamin and iron tablets.  It is observed that the 
doctors are well aware of these additional pills, which are good source of iron 
and vitamin and this awareness is reflected in their advice and prescription.  
 
Perception of Low Dose Pill 
 
As oral contraceptives have a lot of side effects, normally doctors go for low dose 
pills to avoid inconvenience and risk when prescribing a patient.  Thus knowing 
about doctors' perception regarding low dose pill, especially how the doctors 
generally define them, is very important.   
 
When the doctors were asked to define low dose pill, the responses were as 
follows (Table 2).  
 
TABLE 2 
DOCTORS' RESPONSES ABOUT LOW DOSE PILL 
 
Perception about low dose pill % 
Lower level of estrogen & progesterone (female sex hormones) 44 
Less side effect 28 
Estrogen level < 50 mg & Progesterone level is ≤1.5 mg 28 
Total 100 
 
As observed the doctors are divided in their opinions as to the definition of low 
dose pills.  About 44% doctors define low dose oral contraceptives as those, 
which has lower level of estrogen and progesterone hormones because the dose 
depends upon the level of these two hormones.  It is worth noting that these 44% 
doctors are not specific in defining lower level.  Again another 28% doctors think 
that low dose oral contraceptives are those that cause less side effect to its user 
due to its lower level of hormones.  But the rest 28% doctors could define the low 
dose pill in a perfect term.  These 28% doctors define the low dose pill as 
contraceptive with estrogen level less than 50 mg and progesterone level less 
than or equal to 1.5 mg, which is the medical definition of low dose pill.  Hence, 
we can conclude that in many cases doctors' give their own subjective judgment 
in prescribing low dose pills.  Hence, while recommending contraceptives to a 
patient a number of factors influence the doctors.  
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Quality Perception of Different Oral Contraceptive Brands 
 
Quality has no unique definition.  Normally quality is considered to be meeting 
or exceeding customer satisfaction. The study found that the users of 
contraceptives are mainly concern about its side effects (e.g., hypertension, 
weight gain, breast cancer, etc.) and non-acceptability to their body (nausea, 
vomiting, headache, insomnia, etc.).  Hence, in the study we have considered 
these two quality dimensions for different brands of contraceptives available in 
the market.  
 
The four most common contraceptives available in the market are (1) Marvelon, 
(2) Nordette 28, (3) Ovostat and (4) Femicon.  A cross quality comparison among 
the four brands – Marvelon, Nordette 28, Ovostat and Femicon – was carried out 
in terms of (a) less side effect and (b) acceptability to patients.  A 5-point Likert 
scale (1 → least and 5 → most) was used to determine quality perception of the 
brands.  To further analyse the findings of mean preference score for less side 
effect and acceptability of the brands to the patients, statistical measures, like 
ANOVA and Tukey's critical value were used.  The results of each of them are 
shown below. 
 
Side Effect  
 
Mean Preference Score 
 
The Table 3 summarizes the results with respect to less side effects.  It is noted 
that, Nordette 28 (1.59) and Marvelon (1.61) seems to have least side effects as 
perceived by the doctors, whereas, Ovostat (2.04) and Femicon (2.21) are found 
to have comparatively more side effects.  Note that absolute value wise none of 
the figures are much on the higher side but here comparisons are made in a 
relative scale.  
 
TABLE 3 
MEAN PREFERENCE SCORE OF LESS SIDE  
EFFECT FOR DIFFERENT BRANDS 
 
Brands Mean score (1 –  5 scale)* 
1.  Nordette 28 1.59 
2.  Marvelon 1.61 
3.  Ovostat 2.04 
4.  Femicon 2.21 
* 1 → least side effect & 5 → most side effect 
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Cross Quality Comparison 
 
i. Analysis of Variance (ANOVA) 
 
To check if the means are different or not, the one way analysis of variance 
summarizes ANOVA result regarding less side effects (Table 4).  As calculated 
value [F0.95 (3, 396) = 18.7448] is larger than the critical value at 95% confidence 
level (2.60), it can be concluded that the means are different at a level of 
significance α = 0.05. Nordette 28 has the lowest mean (1.59), followed by 
Marvelon (1.61). 
 
TABLE 4 
ANOVA RESULTS FOR LESS SIDE EFFECT 
 
Brand name Mean 
response 
Source of 
variation 
Sum of 
square 
Degrees of 
freedom 
Mean square F-Ratio 
 
Femicon 2.21 Between 
response 
29.0275 3 9.6758 18.744 
Ovostat 2.04   
Marvelon 1.61 Within 
response 
204.41 396 0.5162  
Nordette 28 1.59   
  Total 233.4375 399   
 
 
ii. Tukey's W Procedure 
 
Tukey's W procedure is applied as the multiple comparison procedure to find out 
which means of the treatments differ significantly from which ones. The 
calculations are shown below (Table 5). 
 
Tukey's critical value = q
0.95, 3, 396 =  (WMS/k)
½ 
WMS = Within Mean Square = 0.5162 
K = number of observations within a sample = 100 
So, the calculated Tukey's critical value = 0.071846 
 
TABLE 5 
COMPARISON OF TUKEY'S CRITICAL VALUE AGAINST DIFFERENT BRANDS 
 
Brand name Means (Xc) Xc – Xn Xc – Xm Xc – Xo 
Femicon (Xf) 2.21 0.62 0.6 0.17 
Ovostat (Xo) 2.04 0.45 0.43  
Marvelon (Xm) 1.61 0.02   
Nordette 28 (Xn) 1.59    
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Comparing the differences in the above table with the critical value 0.071846, the 
only hypothesis Ho: µmarvelon = µnordette is accepted.  So it can be concluded that 
doctors have the same quality perception about Marvelon and Nordette 28 in 
terms of less side effect.  The lowest mean values of these two brands suggest 
that these brands have better quality perception to doctors compare to Ovostat 
and Femicon.  Doctors perceived Femicon as the oral contraceptive with least 
quality among these four brands in terms of less side effect.  
 
Acceptability 
 
Mean Preference Score 
 
The following Table 6 shows brands with mean acceptability preference score. 
Regarding acceptability of brands, it is found that Nordette 28 (1.78), and 
Marvelon (1.79) are the most acceptable brand among the four.  They have 
almost the same acceptability. These are followed by Ovostat (2.19), and 
Femicon (2.55). 
 
TABLE 6 
BRANDS WITH MEAN ACCEPTABILITY PREFERENCE SCORE 
 
Brands Mean score (1 – 5 scale)* 
1.  Nordette 28 1.78 
2.  Marvelon 1.79 
3.  Ovostat 2.19 
4.  Femicon 2.55 
* 1 → most acceptable & 5 → least acceptable 
 
 
Cross Quality Comparison  
 
i. Analysis of Variance (ANOVA) 
 
The one-way analysis of variance table for acceptability to patients summarizes 
ANOVA results in Table 7. As calculated value [F0.95 (3, 396) = 29.8684] is larger 
than the critical value at 95% confidence level (2.60), it can be concluded that the 
means are different at a level of significance α = 0.05. 
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TABLE 7 
ANOVA RESULTS FOR ACCEPTABILITY TO PATIENTS 
 
Brand name Mean 
response 
Source of 
variation 
Sum of 
square 
Degrees of 
freedom 
Mean 
square 
F-Ratio 
(α = 0.05) 
Femicon 2.55 Between 
response 
40.7075 3 13.5692 29.8684 
Ovostat 2.19   
Marvelon 1.79 Within 
response 
179.89 396 0.4543  
Nordette 28 1.78   
  Total 220.5975 399   
  
ii. Tukey's W Procedure 
 
Tukey's W Procedure for multiple comparisons is used to find out the 
interrelation among the mean of rate responses, specifically, to find out which 
means of the treatments differ significantly from which ones. The calculations 
are shown below (Table 8). 
 
Tukey's critical value = q0.95, 3, 396 =  (WMS/k)½ 
WMS = Within Mean Square = 0.4543 
K = number of observations within a sample = 100 
So, the calculated Tukey's critical value = 0.0674 
 
TABLE 8 
COMPARISON OF TUKEY'S CRITICAL VALUE AGAINST  
DIFFERENT BRANDS 
 
Brand name Means (Xc) Xc – Xm Xc – Xn Xc – Xo 
Femicon 2.55 0.77 0.76 0.36 
Ovostat 2.19 0.41 0.4  
Nordette 1.78 0.01   
Marvelon 1.79    
 
Comparing the differences in the above table with the critical value 0.0674, the 
only hypothesis Ho: µnordette = µmarvelon is accepted.  So it can be concluded that 
doctors have the same quality perception about Marvelon and Nordette 28 in 
terms of acceptability to patients.  The lowest mean values of these two brands 
suggest that these brands have better quality perception to doctors compare to 
Ovostat and Femicon.  
 
In summary we can say that the doctors perceive both Nordette 28 and Marvelon 
as oral contraceptives of same quality in respect of less side effect and 
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acceptability to patients.  Doctors perceived Femicon as the oral contraceptive 
with least quality among these four brands in terms of acceptability, as well as, 
side effect.  
 
Factors That Influence Doctors to Prescribe/Advice a Particular Oral 
Contraceptive  
 
A correspondence analysis tool is used to measure the relationship between the 
factors that influence the doctors to prescribe a certain brand of oral 
contraceptive.  In the study as many as nine factors were identified which doctors 
have mentioned as reasons that influence them to prescribe particular brands of 
oral contraceptives.  These are: (1) less side effect, (2) patients' preference,        
(3) low price, (4) low dose, (5) reasonably effective, (6) reasonable price,          
(7) high dose, (8) status due to high price, and (9) mini pill.  The bi-variate 
contingency relationship between the commonly used brand names that doctors 
usually prescribe/advice and reasons behind their choices are shown in Table 9.   
 
TABLE 9 
RELATIONSHIP BETWEEN DOCTOR'S CHOICE OF A BRAND AND REASON OF CHOICE 
 
 
Brand name 
Less 
side 
effect 
Patients'  
prefer- 
ence 
Low 
price 
Low  
dose 
Reason- 
ably 
effective 
Reason- 
able  
price 
High  
dose 
Status 
due to 
high price 
Mini 
pill 
Total 
Marvelon 12 7 1 1 – 6 – 5 – 32 
Nordette 28 6 8 1 3 – 6 – – – 24 
Femicon 2 – 26 – – – – – – 28 
Ovostat 1 – – – 2 – 5 2 – 10 
Nordette* 1 – – – – – – 3 – 4 
Postinor – – – – – – – – 1 1 
Diane 35 1 – – – – – – – – 1 
Total 23 15 28 4 2 12 5 10 1 100 
* Nordette is different from Nordette 28. Nordette 28 is an updated version of Nordette. 
 
From the table it can be seen that the four brands (e.g., Femicon, Marvelon, 
Ovostat and Nordette 28) are accounted for 94% of responses.  The rest three are 
not prescribed much by the doctors.  Similarly, there are two factors (mini pills 
and reasonably effective) are found less considered by the doctors while 
advising.  The other seven important factors (less side effect, patients' preference, 
low price, low dose, reasonable price, high dose, status due to high price), are 
found to be accounted for 97% of the response. In order to use the 
correspondence analysis, these four prominent brands and seven principal factors 
were selected.  With these four brands and seven factors 92% of total responses 
are explained (Table 10).  
 
 
 
 
21 
Muhammad Ziaulhaq Mamun 
TABLE 10 
RELATIONSHIP BETWEEN SELECTED BRANDS AND THE SELECTED REASONS 
 
 
Brand name 
Less 
side 
effect 
Patients'  
preference 
Low 
price 
Low 
dose 
Reasonable 
price 
High 
dose 
Status due 
to high 
price 
Total 
Marvelon 12 7 1 1 6 – 5 32 
Nordette 28 6 8 1 3 6 – – 24 
Femicon 2 – 26 – – – – 28 
Ovostat 1 – – – – 5 2 8 
Total 21 15 28 4 12 5 7 92 
 
Following row profile Table 11 shows the contribution of each factor to the 
brands and the total inertia. Total inertia measures the percentage of total 
attributes explaining each brand. The table manifests the response percentage of 
factors regarding each brand and the major findings in this regard are: 
 
• High dose factor is related to Ovostat only. 
• Less side effect, patients' preference, low dose and reasonable price – these 
four factors explain the reason of prescribing Marvelon and Nordette 28.  
• Femicon is largely prescribed for its low price.  
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TABLE 11 
ROW PROFILE SCORES FOR PRESCRIBING ATTRIBUTES 
 
Brand name Less side 
effect 
Patients' 
preference 
Low  
price 
Low  
dose 
Reason- 
able  
price 
High  
dose 
Status due  
to high  
price 
Total 
inertia 
Marvelon 0.375 0.219 0.031 0.031 0.188 0.000 0.156 0.214 
Nordette 28 0.250 0.333 0.042 0.125 0.250 0.000 0.000 0.217 
Femicon 0.071 0.000 0.929 0.000 0.000 0.000 0.000 0.285 
Ovostat 0.125 0.000 0.000 0.000 0.000 0.625 0.250 0.284 
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Ovostat
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0
2
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Marvelon Nordette 28 Femicon Ovostat
 
Figure 1. Position of brands according to the factors 
 
Figure 1 depicts the position of these four brands in relation to the factors that 
describe them.  From the figure it is ostensible that:  
 
• Marvelon and Nordette 28 are very close to each other according to 
attributes that describe them. The row profiles (Table 11) show that low 
dose, less side effect, patients' preference and reasonable price – these four 
factors describe about 28.3% of Marvelon's characteristics and 25% 
characteristics of Nordette-28.  
 
• Ovostat and Femicon are relatively far apart from each other and also from 
Marvelon/Nordette 28 group. Their relative positions as points in the two-
dimensional space indicate the similarities and differences among them with 
respect to the attributes of which doctors like to prescribe or recommend 
them to their patients. First dimension separates Ovostat and Femicon into 
two different quadrants. So these two brands are totally different in terms of 
attributes that has described them.  
 
• Doctors usually like to prescribe Femicon because of its very low price 
compare to other contraceptive brands.  
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• Similarity in two factors (less side effect and status due to high price) 
positioned Ovostat at the same side of Marvelon/Nordette 28 group related 
to second dimension, but second dimension separates Ovostat from 
Marvelon/Nordette 28 group due to the dissimilarity in other five factors.  
Figure 2. Position of factors according to the brands 
Less side effect
Patients' 
preference
Low price
Reasonable 
price
Status due to 
high price
Low dose
High dose
-4
-2
0
2
.5 0 1.5-1
Less side effect Patients' preference
Low price Reasonable price
Status due to high price Low dose
High dose
 
 
Figure 2 shows the inter-correspondence relationship between seven attributes.  It 
is clear from the figure that:  
 
• Low dose, reasonable price and patients' preference – these three factors 
have coincided each other at the same point.  
 
• First dimension separates factor low price from rest of the factors, as this 
factor describes only one brand – Femicon.  
 
• Two factors – status due to high price and less side effect positioned near to 
each other but separated by first dimension as these two factors describe the 
majority portion of Ovostat and a very little of Marvelon.   
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It is because of the geometric correspondence of the two sets of points, in 
position and inertia, that make it possible to merge the two displays into one joint 
display (Figure 3). The advantage of this merger is that a concise graphical 
display representing varied features of the data is obtained in a single picture.         
 
Figure 3.  Joint position of brands with respective attributes 
Less side effect
Patient wants it
Low price
Reasonable price
Status due to 
high price
Low dose
High dose
Marvelon
Nordette 28
Femicon
Ovostat
-4
-2
0
2
0 1.5-1.5
Less side effect Patient wants it
Low price Reasonable price
Status due to high price Low dose
High dose Marvelon
Nordette 28 Femicon
Ovostat
 
 
Geometrically, a particular brand will tend to a position in its space 
corresponding to the attribute categories prominent in that brand profile. 
Similarly, given the display of brand profiles, a particular attribute category will 
tend along the principal axes in the direction of the brands that are relatively 
substantial in that category.  There is no point near the center of the display that 
might have undifferentiated profile distribution as a consequence of the origin 
placed at the center.  From the joint display of the correspondence analysis, it is 
evident that: 
 
• Nordette 28 and Marvelon are considered to be almost near considering the 
attributes – less side effect, low dose, reasonable price and patients' 
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preference. These four factors are the attributes for which doctors usually 
prescribe Marvelon and Nordette 28 to their patients.  
 
• Femicon is separated from the rest of the group due to its low price. Low 
price attribute only explain the reason of prescribing this brand. So, brand 
and attribute have coincided at a single point.  
 
• Ovostat has positioned in between the two attributes that stand for this 
brand. Doctors usually like to prescribe Ovostat and Marvelon to those 
patients who have more purchasing ability and considers price as a quality 
factor. These groups of patients expect more attention and quality medicine 
from their physician. So, status due to high price factor stands both 
between Ovostat and Marvelon. As doctors mentioned this factor in more 
instances as a reason to prescribe Ovostat compare to Mervelon, this factor 
has its position at the fourth quadrant with Ovostat, but still near the 
Marvelon.   
 
 
CONCLUSION 
 
The study of oral contraceptives preference by the doctors is mainly exploratory 
in nature.  Information was collected from 100 practicing doctors from four 
major cities of Bangladesh through a predesigned questionnaire.  The study noted 
a number of reasons to recommend oral contraceptives by the physicians.  
Though the obvious and important use of oral contraceptives is to prevent 
unwanted pregnancy, it is found that awareness about non-contraceptive health 
benefit use of oral contraceptives are also increasing.  The study noted that in 
only 33% cases doctors advise oral contraceptives for birth control purposes, but 
the rest 67% of the cases the doctors recommend to use oral contraceptive for 
other non contraceptive health benefits, such as treatment of dysmenorrhea 
(28%), regularize menstruation (14%), cure anemia (10%), reduce the abnormal 
menstrual blood (6%), help excessive loss of menstrual blood (5%).  About 4% 
doctors administered oral contraceptives to cure infection of fallopian tubes. 
 
As oral contraceptives have a lot of side effects, normally doctors go for low dose 
pills to avoid inconvenience and risk when prescribing a patient.  As observed, 
the doctors are divided in their opinions as to the definition of low dose pills.  
About 44% doctors consider low-dose oral contraceptives as those, which has 
lower level of estrogen and progesterone hormones because the dose depends 
upon the level of these two hormones.  About 28% doctors think that low dose 
oral contraceptives are those, which causes fewer side effects to its user.  But the 
rest 28% doctors define the low dose pill in a perfect medical term as 
"contraceptive with estrogen level less than 50 mg and progesterone level less 
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than or equal to 1.5 mg."  Hence, we can conclude that in many cases doctors 
give their own judgment in prescribing low dose pills.  Hence, while 
recommending a number of factors influence the doctors.  
 
A cross quality comparison among the four most popular brands – Marvelon, 
Nordette 28, Ovostat and Femicon – was carried out in terms of less side effect 
and acceptability showed that, Nordette 28 and Marvelon seems to have least side 
effects and more acceptability as perceived by the doctors; whereas, Ovostat and 
Femicon are found to have comparatively more side effects and less side effects.  
It is further noted that doctors have the same quality perception about Marvelon 
and Nordette 28 in terms of less side effect and acceptability.  Doctors perceived 
Femicon as the least quality oral contraceptive among these four brands in terms 
of less side effect and acceptability.  
 
The contribution of each of the seven most important factors (less side effect, 
patients' preference, low price, low dose, reasonable price, high dose, status due 
to high price), which doctors have mentioned as reasons that influence them to 
prescribe particular brands of oral contraceptives, to the commonly used brands 
that doctors usually prescribe/advice (Femicon, Marvelon, Ovostat and Nordette 
28) reveals that high dose factor is related to Ovostat only.  Less side effect, 
patients' preference, low dose and reasonable price – these four factors explain 
the reason of prescribing Marvelon and Nordette 28; whereas, Femicon is largely 
prescribed for its low price.  It is noted that Marvelon and Nordette 28 are very 
close to each other according to attributes that describe them, and Ovostat and 
Femicon are relatively far apart from each other and also from Marvelon/ 
Nordette 28 group.  With respect to less side effect and status due to high price, 
Ovostat is similar to Marvelon/Nordette 28 group, but regarding other five 
factors they are dissimilar. 
 
The inter correspondence relationship among seven attributes reveals that the 
three factors – low dose, reasonable price and patients' preference – have 
coincide each other at the same point, and low price is found distinctly separate 
from rest of the factors.  The two factors – status due to high price and less side 
effect – positioned near to each other as these two factors describe the majority 
portion of Ovostat and a very little of Marvelon.  From the joint display of the 
correspondence analysis, it is evident that Nordette 28 and Marvelon are 
considered to be almost near considering the attributes – less side effect, low 
dose, reasonable price and patients' preference. These four factors are the 
attributes for which doctors usually prescribe Marvelon and Nordette 28 to their 
patients.  Femicon is separated from the rest of the group due to its low price, and 
doctors usually like to prescribe Ovostat and Marvelon to those patients who 
have more purchasing ability and considers price as a quality factor. These 
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28 
groups of patients expect more attention and quality medicine from their 
physician.  
 
Even in oral contraceptive market, customer segmentation is very much present. 
From survey, it is clearly evident that doctors, the prescribers themselves, 
segregate the leading four brands of oral contraceptives in three different groups 
according to their ability to satisfy different customer needs.  Therefore, if the 
marketers place and promote these four brands in line with the study findings, it 
would bring them more benefits.  
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